Your browser doesn't support javascript.
loading
Real-world utilization of PD-1/PD-L1 inhibitors with palliative radiotherapy in patients with metastatic non-small cell lung cancer.
Zhou, Zi-Chao; Chen, Kai-Yan; Li, Na; Xie, Ming-Ying; Sheng, Jia-Min; Fan, Yun; Huang, Zhi-Yu.
Afiliación
  • Zhou ZC; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
  • Chen KY; Department of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, China.
  • Li N; Department of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, China.
  • Xie MY; Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.
  • Sheng JM; Department of Thoracic Medical Oncology, The Cancer Hospital of the University of Chinese Academy of Science (Zhejiang Cancer Hospital), Hangzhou, China.
  • Fan Y; The First Clinical Medical College of Wenzhou Medical University, Wenzhou, China.
  • Huang ZY; The Second Clinical Medical College of Zhejiang Chinese Medical University, Hangzhou, China.
Thorac Cancer ; 13(16): 2291-2300, 2022 08.
Article en En | MEDLINE | ID: mdl-35762488
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Thorac Cancer Año: 2022 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Neoplasias Pulmonares Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Thorac Cancer Año: 2022 Tipo del documento: Article País de afiliación: China